Search results for "Cytokine Storm"

showing 10 items of 23 documents

Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and …

2019

Immunomodulatory glycolipids, among which α-galactosylceramide (KRN7000) is an iconic example, have shown strong therapeutic potential in a variety of conditions ranging from cancer and infection to autoimmune or neurodegenerative diseases. A main difficulty for those channels is that they often provoke a cytokine storm comprising both pro- and anti-inflammatory mediators that antagonize each other and negatively affect the immune response. The synthesis of analogues with narrower cytokine secretion-inducing capabilities is hampered by the intrinsic difficulty at controlling the stereochemical outcome in glycosidation reactions, particularly if targeting the α-anomer, which seriously hamper…

Allosteric regulationIminosugar01 natural sciencesImmunomodulation03 medical and health sciencesGlycolipidGlycomimeticDrug DiscoverymedicineLeishmaniasisp38α MAPKCancer030304 developmental biologyInflammationPharmacology0303 health sciences010405 organic chemistryChemistryOrganic ChemistryAutophosphorylationBiological activityGeneral Medicinemedicine.disease0104 chemical sciencessp2-Iminosugar glycolipidsBiochemistryMechanism of actionPolyfluoroalkyl compoundsmedicine.symptomCytokine stormEuropean Journal of Medicinal Chemistry
researchProduct

Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches

2020

Great efforts are being made worldwide to identify the specific clinical characteristics of infected critically ill patients that mediate the associated pathogenesis, including vascular dysfunction, thrombosis, dysregulated inflammation, and respiratory complications. Recently, coronavirus disease 2019 has been closely related to sepsis, which suggests that most deaths in ICUs in infected patients are produced by viral sepsis. Understanding the physiopathology of the disease that lead to sepsis after severe acute respiratory syndrome coronavirus 2 infection is a current clinical need to improve intensive care-applied therapies applied to critically ill patients. Although the whole represent…

Critical CareAnti-Inflammatory AgentsInflammationDiseaseCritical Care and Intensive Care MedicinesepsisSepsisPathogenesis03 medical and health sciences0302 clinical medicineImmune systemCoagulopathymedicineHumansanti-inflammatory therapyGlucocorticoidsRespiratory Distress SyndromeSARS-CoV-2business.industryCOVID-19Thrombosis030208 emergency & critical care medicineBlood Coagulation Disordersmedicine.diseaseThrombosisPathophysiologyViewpoints030228 respiratory systemcytokine stormImmunologyCytokinesmedicine.symptombusinesssevere acute respiratory syndrome coronavirus 2Critical Care Medicine
researchProduct

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism

2021

International audience; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of respiratory and cardiovascular diseases, known as coronavirus disease 2019 (COVID-19). SARS-CoV-2 encodes the structural proteins spike (S), envelope (E), membrane (M), and nucleocapsid (N). The receptor-binding domain on the surface subunit S1 is responsible for attachment of the virus to angiotensin (Ang)-converting enzyme 2 (ACE2), which is highly expressed in host cells. The cytokine storm observed in patients with COVID-19 contributes to the endothelial vascular dysfunction, which can lead to acute respiratory distress syndrome, multiorgan failure, alteration in iron homeostasi…

Glial Cell Line-Derived Neurotrophic Factor ReceptorsGrowth Differentiation Factor 15Endocrinology Diabetes and MetabolismRegulatorApoptosisReviewBiologyVirus03 medical and health sciences0302 clinical medicineEndocrinologyMediatorironViral life cycleImmunity[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesPyroptosismedicineHumansImmunologic Factors030304 developmental biology0303 health sciences[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseasesSARS-CoV-2COVID-19Prognosismedicine.diseaseCOVID-19 Drug Treatment3. Good healthOxidative StresstherapeuticGDF15030220 oncology & carcinogenesisImmunology[SDV.IMM]Life Sciences [q-bio]/ImmunologyEndothelium VascularGDF15Cytokine Release SyndromeCytokine stormmetabolismTransforming growth factorTrends in Endocrinology and Metabolism
researchProduct

Immunosuppression Drugs Seize the Overacting Immune System by Preventing the Cytokine Storm In COVID-19 Symptoms

2021

The COVID-19 over-active other diseases within the human body especially respiratory system in which cytokine storm abnormally developed that results in the excessive killing of cells within the autoimmune system. To resolve this major issue, a systematic review paper is developed whose major aim is to propose such immunosuppression drugs that can easily seize the overacted immune system by blocking the cytokine storm action within human body, by systematically overview the previous scholars' articles, case reports and authentic websites based valid data. To justify this aim, different latest and authentic medicine's journals and papers are collected by posting four major keywords like "Cyt…

Immunosuppression Drugsautoimmune systemCOVID-19Cytokine StormSystematic Reviews in Pharmacy
researchProduct

Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)

2020

Abstract Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory disease, which can evolve into multi-organ failure (MOF), leading to death. Several biochemical alterations have been described in COVID-19 patients. To date, many biomarkers reflecting the main pathophysiological characteristics of the disease have been identified and associated with the risk of developing severe disease. Lymphopenia represents the hallmark of the disease, and it can be detected since the early stage of infection. Increased levels of several inflammatory biomarkers, including c-reactive protein, have been found in COVID-19 patients and associ…

Kidney DiseaseClinical BiochemistryMyocardial InfarctionMedicine (miscellaneous)Disease030204 cardiovascular system & hematologySeverity of Illness Index0302 clinical medicineBiomarkers Coronavirus Infection030212 general & internal medicinebiochemical alterationAged 80 and overHealth PolicyLiver DiseasesMusclesLiver DiseaseRespiratory diseaseBlood Coagulation DisordersWater-Electrolyte BalancePathophysiologyC-Reactive ProteinDisease ProgressionCytokinesbiomarkerMuscleKidney DiseasesLiver dysfunctionCoronavirus InfectionsHumanCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viralmacromolecular substances03 medical and health sciencesBetacoronavirusLymphopeniamedicineHumansCytokinePandemicsAgedInflammationBlood Coagulation DisorderBetacoronavirubusiness.industrySARS-CoV-2Biochemistry (medical)Public Health Environmental and Occupational HealthCOVID-19Biochemical biomarkersmedicine.diseaseImmunologyCytokine stormbusinesslaboratoryBiomarkers
researchProduct

More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review

2020

Despite safety recommendations for the management of corpses with COVID-19 infection and the high number of deaths worldwide, the post-mortem investigation rate is extremely low as well as the scientific contributions describing the pathological features. The first results of post-mortem investigations provided interesting findings and contributed to promoting unexplored therapeutic approaches and new frontiers of research. A systematic review is provided with the aim of summarizing all autopsy studies up to February 2020 in which a complete post-mortem investigation in patients with COVID-19 disease was performed, focusing on histopathological features. We included case reports, case serie…

Microbiology (medical)medicine.medical_specialtyARDSAutopsyReviewDisease030204 cardiovascular system & hematologyCytokine stormMicrobiology03 medical and health sciences0302 clinical medicineautopsyVirologymedicineMedical historydiffuse alveolar damage (DAD)acute kidney injury (AKI)Intensive care medicineProspective cohort studyPathologicallcsh:QH301-705.5COVID-19; autopsy; diffuse alveolar damage (DAD); acute respiratory distress syndrome (ARDS); microthrombosis; acute kidney injury (AKI); cytokine stormmicrothrombosisbusiness.industryGold standardacute respiratory distress syndrome (ARDS)COVID-19medicine.diseasePneumonialcsh:Biology (General)030220 oncology & carcinogenesiscytokine stormmicrothrombosibusinessMicrothrombosis.Microorganisms
researchProduct

Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?

2021

The outcomes of Coronavirus disease-2019 (COVID-19) vary depending on the age, health status and sex of an individual, ranging from asymptomatic to lethal. From an immunologic viewpoint, the final severe lung damage observed in COVID-19 should be caused by cytokine storm, driven mainly by interleukin-6 and other pro-inflammatory cytokines. However, which immunopathogenic status precedes this “cytokine storm” and why the male older population is more severely affected, are currently unanswered questions. The aging of the immune system, i.e., immunosenescence, closely associated with a low-grade inflammatory status called “inflammageing,” should play a key role. The remodeling of both innate …

QH301-705.5Reviewstem cell transplantationCell and Developmental BiologyImmune systemImmunopathologyMedicineimmunopathologyBiology (General)immunosenescenceSettore MED/04 - Patologia Generalebusiness.industryMesenchymal stem cellCOVID-19Cell BiologyImmunosenescenceAcquired immune systemmedicine.diseaseTransplantationImmunologycytokine stormStem cellCOVID-19; cytokine storm; immunopathology; immunosenescence; stem cell transplantationbusinessCytokine stormDevelopmental Biology
researchProduct

Flavonoids against the SARS-CoV-2 induced inflammatory storm

2021

The disease severity of COVID-19, especially in the elderly and patients with co-morbidities, is characterized by hypercytokinemia, an exaggerated immune response associated with an uncontrolled and excessive release of proinflammatory cytokine mediators (cytokine storm). Flavonoids, important secondary metabolites of plants, have long been studied as therapeutic interventions in inflammatory diseases due to their cytokine-modulatory effects. In this review, we discuss the potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity. The immunomodulatory ability of flavonoids, carried out …

Settore BIO/17 - Istologia0301 basic medicinePhytochemicalsAnti-Inflammatory AgentsAnti-inflammatory effectsInflammationRM1-950ReviewCytokine stormProinflammatory cytokineImmunomodulationEndothelial activation03 medical and health sciences0302 clinical medicineImmune systemAnimalsHumansMedicineDipeptidyl peptidase-4InflammationFlavonoidsPharmacologySARS-CoV-2business.industryfungiCOVID-19food and beveragesInflammasomeGeneral Medicinemedicine.diseaseCOVID-19 Drug Treatment3. Good health030104 developmental biology030220 oncology & carcinogenesisImmunologyTherapeutics. Pharmacologymedicine.symptomSignal transductionCytokine Release SyndromebusinessCytokine stormmedicine.drugBiomedicine & Pharmacotherapy
researchProduct

Coagulation disorders in SARS-CoV-2 infection

2020

A better understanding of the pathogenetic mechanisms triggered by SARS-CoV-2 infection may contribute to a more effective management of patients with COVID-19. Coagulation dysfunction is a key pathogenetic element of this disease as well as a challenge for practitioners. Marked inflammatory process found in severe forms of COVID-19, the complement activation, the cytokine storm, and disruption of the renin-angiotensin-aldosterone system are involved in the onset of thrombotic microangiopathy and large vessel coagulopathy. Virus-induced procoagulant activity occurs at the systemic level. Intravascular microthrombi disrupt vascularization in various tissues and organs, contributing to the oc…

medicine.medical_specialtyThrombotic microangiopathylcsh:Medicine030204 cardiovascular system & hematologyheparinGastroenterologyGeneral Biochemistry Genetics and Molecular BiologyFibrin03 medical and health sciences0302 clinical medicineIntensive careInternal medicinemedicineCoagulopathyCoagulation Disorderthrombosisbiologybusiness.industrylcsh:Rmedicine.diseaseThrombosissars-cov-2Coagulationcovid-19coagulation disorders030220 oncology & carcinogenesisbiology.proteinbusinessCytokine stormBiomedical Papers
researchProduct

Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19

2020

Hospital admissions and mortality from the Coronavirus disease 2019 (COVID-19) pandemic are spreading throughout the world, and second and third waves are thought to be likely. Risk factors for severe COVID-19 include diabetes, chronic kidney disease and cardiovascular disease. Currently, there is no vaccine and no approved therapy. Therapeutic approaches are aimed at preventing viral replication and spread, limiting the impact of the inflammatory overdrive (cytokine storm), preventing thromboembolic complications and replacing or supporting organ function. However, despite organ support, mortality is currently 65% for those receiving advanced respiratory support and 78% for those requiring…

medicine.medical_specialtyempagliflozinEmpagliflozinlcsh:MedicineContext (language use)ReviewDisease030204 cardiovascular system & hematologyCardiovascularSGLT203 medical and health scienceschemistry.chemical_compound0302 clinical medicineChronic kidney diseaseDiabetes mellitusmedicine030212 general & internal medicineCanagliflozinDapagliflozincanagliflozinIntensive care medicinediabetesbusiness.industrycardiovascularDiabeteslcsh:RCOVID-19dapagliflozinGeneral MedicineDapagliflozinmedicine.diseaseVirusClinical trialRespiratory failurechemistryCytokine stormbusinesschronic kidney diseaseKidney diseaseJournal of Clinical Medicine
researchProduct